Clinical Trials Browser

Phase 2 × Non-Muscle Invasive Bladder Neoplasms × enzalutamide × Clear all

NCT02605863 2018-10-03

Enzalutamide for Bladder Cancer Chemoprevention

Phase 2 Terminated

1 enrolled 6 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms